Unknown

Dataset Information

0

Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina.


ABSTRACT: Retinitis pigmentosa (RP), an inherited retinal degenerative disease, is characterized by a progressive loss of rod photoreceptors followed by loss of cone photoreceptors. Previously, when tissue inhibitor of metalloproteinase 1 (TIMP1), a key extracellular matrix (ECM) regulator that binds to and inhibits activation of Matrix metallopeptidase 9 (MMP9) was intravitreal injected into eyes of a transgenic rhodopsin rat model of RP, S334ter-line3, we discovered cone outer segments are partially protected. In parallel, we reported that a specific MMP9 and MMP2 inhibitor, SB-3CT, interferes with mechanisms leading to rod photoreceptor cell death in an MMP9 dependent manner. Here, we extend our initial rat studies to examine the potential of TIMP1 as a treatment in retinal degeneration by investigating neuroprotective effects in a classic mouse retinal degeneration model, rdPde6b-/- (rd1). The results clearly demonstrate that intravitreal injections of TIMP1 produce extended protection to delay rod photoreceptor cell death. The mean total number of rods in whole-mount retinas was significantly greater in TIMP-treated rd1 retinas (postnatal (P) 30, P35 (P<0.0001) and P45 (P<0.05) than in saline-treated rd1 retinas. In contrast, SB-3CT did not delay rod cell death, leading us to further investigate alternative pathways that do not involve MMPs. In addition to inducing phosphorylated ERK1/2, TIMP1 significantly reduces BAX activity and delays attenuation of the outer nuclear layer (ONL). Physiological responses using scotopic electroretinograms (ERG) reveal b-wave amplitudes from TIMP1-treated retinas are significantly greater than from saline-treated rd1 retinas (P<0.05). In later degenerative stages of rd1 retinas, photopic b-wave amplitudes from TIMP1-treated rd1 retinas are significantly larger than from saline-treated rd1 retinas (P<0.05). Our findings demonstrate that TIMP1 delays photoreceptor cell death. Furthermore, this study provides new insights into how TIMP1 works in the mouse animal model of RP.

SUBMITTER: Kim HS 

PROVIDER: S-EPMC5942829 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina.

Kim Hwa Sun HS   Vargas Andrew A   Eom Yun Sung YS   Li Justin J   Yamamoto Kyra L KL   Craft Cheryl Mae CM   Lee Eun-Jin EJ  

PloS one 20180509 5


Retinitis pigmentosa (RP), an inherited retinal degenerative disease, is characterized by a progressive loss of rod photoreceptors followed by loss of cone photoreceptors. Previously, when tissue inhibitor of metalloproteinase 1 (TIMP1), a key extracellular matrix (ECM) regulator that binds to and inhibits activation of Matrix metallopeptidase 9 (MMP9) was intravitreal injected into eyes of a transgenic rhodopsin rat model of RP, S334ter-line3, we discovered cone outer segments are partially pro  ...[more]

Similar Datasets

| S-EPMC1223442 | biostudies-other
| S-EPMC4294659 | biostudies-literature
| S-EPMC5624544 | biostudies-literature
| S-EPMC2599898 | biostudies-literature
| S-EPMC5746594 | biostudies-literature
| S-EPMC7546330 | biostudies-literature
| S-EPMC4853344 | biostudies-literature
| S-EPMC1151465 | biostudies-other
| S-EPMC4383516 | biostudies-literature
| S-EPMC3240149 | biostudies-literature